List view / Grid view
2 June 2014 | By AstraZeneca
As part of the 50th Annual Meeting of the American Society for Clinical Oncology (ASCO), Dr Joyce Liu presented data on a Phase II study conducted by the American National Cancer Institute...
2 June 2014 | By Amgen
...in patients with a rare and serious genetic disorder that causes high cholesterol.
2 June 2014 | By kdm communications
Avacta Analytical is pleased to announce its sponsorship of this year’s Protein Formulation Development and Drug Delivery Forum in Barcelona, Spain...
30 May 2014 | By Biogen Idec
Biogen Idec received a positive recommendation from the Committee for Medicinal Products for Human Use of the European Medicines Agency for the marketing authorisation of PLEGRIDY...
30 May 2014 | By Biogen Idec
Biogen Idec announced that more than 60 company-sponsored presentations highlighting key data from its industry-leading portfolio of marketed and investigational multiple sclerosis therapies are being featured during two neurology conferences...
30 May 2014 | By Pfizer
Pfizer Inc. announced that Morris J. Birnbaum, M.D., Ph.D., has joined the company as Chief Scientific Officer for Cardiovascular and Metabolic Disease Research...
30 May 2014 | By Sanofi
Sanofi and its subsidiary Genzyme announced that the U.S. Food and Drug Administration has accepted for review the company’s resubmission of its supplemental Biologics License Application (sBLA) seeking approval of Lemtrada...
29 May 2014 | By The European Medicines Agency
The European Medicines Agency welcomes the publication of the Clinical Trials Regulation in the Official Journal of the European Union...
29 May 2014 | By Boehringer Ingelheim
Boehringer Ingelheim announced that the company has reached a comprehensive settlement of state and federal cases in the U.S. litigation regarding Pradaxa®...
29 May 2014 | By H. Lundbeck A/S
Data highlights safety and efficacy profile of Brintellix, including difficult to treat patients and special patient populations...
28 May 2014 | By Sanofi
Sanofi and Eli Lilly and Company announced an agreement to pursue regulatory approval of nonprescription Cialis (tadalafil)...
28 May 2014 | By Bristol-Myers Squibb Company
Bristol-Myers Squibb Company and Incyte Corporation announced the establishment of a clinical trial collaboration to evaluate the safety, tolerability and preliminary efficacy of a combination regimen...
28 May 2014 | By Pfizer
The nation’s most prescribed acid blocker brand is now available without a prescription at retailers nationwide...
28 May 2014 | By Teva
Teva Pharmaceutical Industries Ltd. announced that the European Patent Office issued a decision in favor of Teva in a patent opposition proceeding filed by Synthon BV, Mylan and an unidentified third party...
28 May 2014 | By Amgen
New data reinforces commitment to personalized medicine and highlights advances in immunotherapy platform...
